Nanoparticle-based multivalent human antibodies offer potent and broad neutralization against Omicron sublineages

Signal Transduct Target Ther. 2023 Aug 2;8(1):284. doi: 10.1038/s41392-023-01512-6.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Immunoglobulins*

Substances

  • Immunoglobulins